Nextwave Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NEXTWAVE PHARMS, and what generic alternatives to NEXTWAVE PHARMS drugs are available?
NEXTWAVE PHARMS has one approved drug.
There are nine US patents protecting NEXTWAVE PHARMS drugs.
There are thirty-four patent family members on NEXTWAVE PHARMS drugs in fourteen countries.
Drugs and US Patents for Nextwave Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nextwave Pharms | QUILLICHEW ER | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE, CHEWABLE;ORAL | 207960-003 | Dec 4, 2015 | RX | Yes | Yes | 11,103,494 | See Plans and Pricing | Y | See Plans and Pricing | |||
Nextwave Pharms | QUILLICHEW ER | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE, CHEWABLE;ORAL | 207960-001 | Dec 4, 2015 | RX | Yes | No | 10,857,143 | See Plans and Pricing | Y | See Plans and Pricing | |||
Nextwave Pharms | QUILLICHEW ER | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE, CHEWABLE;ORAL | 207960-001 | Dec 4, 2015 | RX | Yes | No | 11,103,494 | See Plans and Pricing | Y | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Nextwave Pharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 5479086 | See Plans and Pricing |
Israel | 194042 | See Plans and Pricing |
Denmark | 2884961 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.